期刊文献+

布氏锥虫苯丙氨酰-tRNA合成酶在大肠杆菌中的克隆、表达、纯化及活性测定

Cloning, expression, purification and activity assay of Trypanosoma brucei phenylalanyl-tRNA synthetase in Escherichia coli
原文传递
导出
摘要 苯丙氨酰-tRNA合成酶是布氏锥虫蛋白合成过程中的一类重要酶,以其为靶点的抑制剂可能发展成为新一代的抗锥虫药物,但此前并没有分离锥虫苯丙氨酸-tRNA合成酶的报道。本研究用大肠杆菌成功克隆表达并纯化了布氏锥虫苯丙氨酰-tRNA合成酶并进行了活性测定。首先通过PCR方法从布氏锥虫细胞基因组中分别扩增出苯丙氨酰-tRNA合成酶的α亚基、β亚基的基因,依次克隆入pCOLADuet共表达载体,然后在大肠杆菌BL21(DE3)RIPL中进行了成功表达,并采用Ni-Bind亲和层析对其进行了纯化,最后用免疫印迹进行了鉴定。此外还采用放射性同位素方法进行了酶活性测定,这为下一步进行布氏锥虫苯丙氨酰-tRNA合成酶抑制物的设计和体外筛选奠定了良好的基础。 Phenylalanyl-tRNA synthetase is a key enzyme for protein synthesis in Trypanosoma. Its validation as an inhibition target will enable the development of a new generation of anti-Trypanosoma drugs. However, little is known about the isolation of the Trypanosoma Phenylalanyl-tRNA synthetase. Here we report the cloning, expression, purification and activity assay of Phenylalanyl-tRNA synthetase from Trypanosoma brucei in Escherichia coli host. We co-cloned the α-subunit and β-subunit of Phenylalanyl-tRNA synthetase from Trypanosoma brucei genomic DNA into the co-expression vector pCOLADuet. We successfully expressed the Trypanosoma brucei Phenylalanyl-tRNA synthetase in E. coli host, purified the whole enzyme by Ni-Hind affinity column and verified it by Western blotting. In addition, we tested its enzymatic activity by isotope labeling. The whole work laid a solid foundation for in vitro the screening and optimization of Trypanosoma brucei phenylalanyl-tRNA synthetase inhibitors.
出处 《生物工程学报》 CAS CSCD 北大核心 2010年第1期130-135,共6页 Chinese Journal of Biotechnology
关键词 布氏锥虫 苯丙氨酰 TRNA合成酶 原核表达 纯化 酶活测定 Trypanosoma brucei, phenylalanyl-tRNA synthetase, prokaryotic expression, purification, enzyme activity assay
  • 相关文献

参考文献13

  • 1Molyneux DH, Hotez PJ, Fenwick A, et al. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor.PLoSMed, 2005, 2(11): 1064-1070.
  • 2Renslo AR, McKerrow JH. Drug discovery and development for neglected parasitic diseases. Nat Chem Biol, 2006, 2(12): 701-710.
  • 3Geary TG, Thompson DP. Development of antiparasitic drugs in the 21st century. Vet Parasitol, 2003, 115(2): 167-184.
  • 4Pink R, Hudson A, Mouries MA, et al. Opportunities and challenges in antiparasitic drug discover. Nat Rev Drug Discov, 2005, 4(9): 727-740.
  • 5Mosyak L, Reshetnikova L, Goldgur Y, et al. Structure of phenylalanyl-tRNA synthetase from Thermus thermophilus. Nat StructMolBiol, 1995, 2(7): 537-547.
  • 6Ling JQ, Yadavalli SS, Ibba M. Phenylalanyl-tRNA synthetase editing defects result in efficient mistranslation of phenylalanine codons astyrosine. RNA, 2007, 13(11): 1881-1886.
  • 7Savopoulos JW, Hibbs M, Jones EJ, et al. Identification, cloning and expression of a functional phenylalanyl-tRNA synthetase (pheRS) from Staphylococcus aureus. Protein Expres Purif, 2001, 21(3): 470-484.
  • 8Bullard JM, Cai YC, Demeler B, et al. Expression and characterization of a human mitochondria phenylalanyl- tRNA synthetase. JMol Biol, 1999, 288(4): 567-577.
  • 9Levin I, Kessler N, Moor N, et al. Purification, crystallization and preliminary X-ray characterization of a human mitochondrial phenylalanyl-tRNA synthetase. Acta Cryst, 2007, 63(9): 761-764.
  • 10Finarov I, Moor N, Kessler N, et al. Crystallization and X-ray analysis of human cytoplasmic phenylalanyl-tRNA synthetase. Acta Cryst, 2009, 65(2): 93-97.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部